Form 8-K · Current report
News Corp 8-K, filed Sep 28, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000210
Summary
News Corp reported that under its 2025 repurchase program it is authorized to buy back up to US$1 billion of its Class A and Class B common stock, and that it had purchased approximately US$498.9 million worth of shares to date. A daily notification to the Australian Securities Exchange recorded 62,323 shares bought back on September 25, 2026 for US$1,771,780.57, bringing cumulative repurchases to 12,422,034 shares.
Key points
- The repurchase authorization, dated July 15, 2025, permits up to an aggregate US$1 billion of Class A and Class B common stock.
- News Corp repurchased 62,323 shares on September 25, 2026 for US$1,771,780.57.
- Cumulative purchases under the program total 12,422,034 shares for US$325,213,425.41, roughly US$498,931,469 based on total consideration paid.
- Goldman Sachs & Co. LLC is named as broker for the program, and the company states the purpose is to enhance shareholder value.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.